Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects With Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 31 de oct de 2016
ID: NCT02914561
Terminado
Fase 3
ClinicalTrials.gov
Open-label Extension Study of Relamorelin for the Treatment of Diabetic Gastroparesis
INTERVENTIONAL
Inicio: 20 de dic de 2018
ID: NCT03786380
Completado
Fase 2
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study on the Safety and Efficacy of Istaroxime for Pre-Cardiogenic Shock (SEISMiC)
INTERVENTIONAL
Inicio: 28 de sept de 2020
ID: NCT04325035
Terminado
Fase 4
ClinicalTrials.gov
A Phase 4, Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Pharmacokinetics and Safety of Obeticholic Acid in Patients With Primary Biliary Cholangitis and Moderate to Severe Hepatic Impairment
INTERVENTIONAL
Inicio: 22 de jun de 2018
ID: NCT03633227
Completado
Fase 3
ClinicalTrials.gov
A 64-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Active Controlled Study to Evaluate the Effect of QVA149 (110/50 μg o.d.) vs NVA237 (50 μg o.d.) and Open-label Tiotropium (18 μg o.d.) on COPD Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 1 de abr de 2010
ID: NCT01120691
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a Randomized, Double-blind, Active-controlled, Parallel-group, Multicenter, Proof-of-concept Clinical Study to Evaluate the Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 20 de nov de 2018
ID: NCT03662542
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
INTERVENTIONAL
Inicio: 13 de feb de 2017
ID: NCT03053050
Terminado
Fase 3
ClinicalTrials.gov
Induction Study #1 - A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 27 de feb de 2018
ID: NCT03440372
Retirado
Fase 3
ClinicalTrials.gov
A Phase IIIb, Multicenter, Randomized, Visual Assessor-Masked Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration
INTERVENTIONAL
Inicio: 29 de dic de 2023
ID: NCT05126966
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-center, Open Label Study of NIR178 in Combination With PDR001 in Patients With Selected Advanced Solid Tumors and Non-Hodgkin Lymphoma
INTERVENTIONAL
Inicio: 28 de ago de 2017
ID: NCT03207867
Completado
Fase 3
ClinicalTrials.gov
A Comparative Study of Chronic Hepatitis B Subjects Treated With Entecavir Plus Tenofovir Combination Therapy vs. Entecavir Monotherapy in Adults Who Are Treatment-Naive to Nucleosides and Nucleotides: The BE-LOW Study
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00410072
Reclutando
Fase 2
ClinicalTrials.gov
A Phase 2, Multinational, Multicenter, Randomized, Doubleblind, Placebocontrolled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR441566 in Adults With Moderate to Severe Crohn's Disease.
INTERVENTIONAL
Inicio: 10 de dic de 2024
ID: NCT06637631
Desconocido
ClinicalTrials.gov
Endoscopic Scoring System Utilization for Inflammatory Bowel Disease Activity Assessment
OBSERVATIONAL
Inicio: 2 de may de 2022
ID: NCT05576402
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blinded Study of IMC-1121B and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy
INTERVENTIONAL
Inicio: 1 de ago de 2009
ID: NCT00917384
Activo, no recluta
Fase 3
ClinicalTrials.gov
ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
INTERVENTIONAL
Inicio: 12 de dic de 2017
ID: NCT03301506
Reclutando
Fase 1
ClinicalTrials.gov
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Inflammatory Bowel Disease
INTERVENTIONAL
Inicio: 11 de jun de 2022
ID: NCT05003947
Completado
Fase 2
ClinicalTrials.gov
Phase-II Immunogenicity Study of a DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO at 2, 4, and 6 Months of Age in Healthy Argentinean Infants
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00831311
Completado
ClinicalTrials.gov
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis Receiving Treatment With Non- Steroidal Anti- Inflammatory Drugs.
OBSERVATIONAL
Inicio: 1 de may de 2012
ID: NCT01577563
Completado
ClinicalTrials.gov
Assessment of Gluten-Free Availability in Elaborated Food Stores in Three Neighbourhoods of Buenos Aires City
OBSERVATIONAL
Inicio: 1 de sept de 2011
ID: NCT02312349
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Global, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Once-daily Oral Avatrombopag for the Treatment of Adults With Thrombocytopenia Associated With Liver Disease Prior to an Elective Procedure
INTERVENTIONAL
Inicio: 1 de nov de 2013
ID: NCT01976104
Anterior
1
...
24
25
26
...
434
Siguiente
Filtros